Mayo Clinic
i-Lumen Reports Dry AMD Signals in i-SIGHT Feasibility Study
i-Lumen Scientific reported findings from a randomized, sham-controlled feasibility study of its investigational AMD System, identifying potential improvements in visual…
SimBioSys wins FDA clearance for AI breast cancer recurrence risk tool
SimBioSys has received FDA 510(k) clearance for TumorSight Risk, which the company describes as the world's first AI-powered, MRI-derived prognostic tool for breast…